{ "cik": 1768224, "cik_padded": "0001768224", "entityName": "Arcturus Therapeutics Holdings Inc.", "fiscal_years": [ { "accn": "0001193125-26-088391", "filed": "2026-03-03", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 230000.0, "cash": 230909000.0, "eps_diluted": -2.4, "free_cash_flow": -74501000.0, "net_income": -65783000.0, "operating_cash_flow": -74271000.0, "operating_income": -76260000.0, "revenue": 82031000.0, "stockholders_equity": 213985000.0, "total_assets": 271148000.0, "total_liabilities": 57163000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.2671355468841274, "net_margin": -0.8019285392107862, "operating_margin": -0.9296485475003352, "revenue_growth_yoy": -0.4614207865537391, "roa_avg2y": -0.21385299821038756, "roa_period_end": -0.24260920235443373, "roe_avg2y": -0.28917955965649955, "roe_period_end": -0.30741874430450733 } }, { "accn": "0001193125-26-088391", "filed": "2026-03-03", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 648000.0, "cash": 237028000.0, "eps_diluted": -3.0, "free_cash_flow": -60395000.0, "net_income": -80941000.0, "operating_cash_flow": -59747000.0, "operating_income": -95669000.0, "revenue": 152310000.0, "stockholders_equity": 240978000.0, "total_assets": 344069000.0, "total_liabilities": 103091000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.4278025379910199, "net_margin": -0.5314227562208653, "operating_margin": -0.6281202810058434, "revenue_growth_yoy": -0.08686502916684152, "roa_avg2y": -0.20929291466648395, "roa_period_end": -0.23524641859626994, "roe_avg2y": -0.31161656313583874, "roe_period_end": -0.33588543352505207 } }, { "accn": "0001193125-26-088391", "filed": "2026-03-03", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 2901000.0, "cash": 292005000.0, "eps_diluted": -1.12, "free_cash_flow": -21000000.0, "net_income": -29725000.0, "operating_cash_flow": -18099000.0, "operating_income": -78205000.0, "revenue": 166799000.0, "stockholders_equity": 278513000.0, "total_assets": 429402000.0, "total_liabilities": 150889000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.5417664525533817, "net_margin": -0.17820850244905548, "operating_margin": -0.46885772696478994, "revenue_growth_yoy": -0.1902921858843975, "roa_avg2y": -0.06757302034919736, "roa_period_end": -0.06922417687854272, "roe_avg2y": -0.1083223249669749, "roe_period_end": -0.10672751361695862 } }, { "accn": "0001193125-26-088391", "filed": "2026-03-03", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 7726000.0, "cash": 391883000.0, "eps_diluted": 0.35, "free_cash_flow": 24267000.0, "net_income": 9349000.0, "operating_cash_flow": 31993000.0, "operating_income": 12177000.0, "revenue": 205999000.0, "stockholders_equity": 270312000.0, "total_assets": 450387000.0, "total_liabilities": 180075000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.6661746426351771, "net_margin": 0.04538371545492939, "operating_margin": 0.0591119374365895, "revenue_growth_yoy": 15.667934298891495, "roa_avg2y": 0.02217502113968081, "roa_period_end": 0.020757703930175606, "roe_avg2y": 0.037506795072644594, "roe_period_end": 0.03458595992778715 } }, { "accn": "0000950170-25-034787", "filed": "2025-03-06", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 3406000.0, "cash": 370492000.0, "eps_diluted": -7.74, "free_cash_flow": -138449000.0, "net_income": -203674000.0, "operating_cash_flow": -135043000.0, "operating_income": -202852000.0, "revenue": 12359000.0, "stockholders_equity": 228211000.0, "total_assets": 392814000.0, "total_liabilities": 164603000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.7212754862824317, "revenue_growth_yoy": 0.295628472586225, "roa_avg2y": -0.46860929285492425, "roa_period_end": -0.5184998498016873, "roe_avg2y": -0.6520029963314148, "roe_period_end": -0.8924810811047671 } }, { "accn": "0001564590-22-007832", "filed": "2024-03-14", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1742000.0, "cash": 462895000.0, "free_cash_flow": -44603000.0, "net_income": -72148000.0, "operating_cash_flow": -42861000.0, "operating_income": -71524000.0, "revenue": 9539000.0, "stockholders_equity": 396553000.0, "total_assets": 476456000.0, "total_liabilities": 79903000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.2014938734544941, "revenue_growth_yoy": -0.5411515705421136, "roa_avg2y": -0.2583176840631652, "roa_period_end": -0.15142636465906611, "roe_avg2y": -0.3416543347263493, "roe_period_end": -0.18193784941735405 } }, { "accn": "0001564590-22-007832", "filed": "2022-03-01", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 818000.0, "cash": 71353000.0, "free_cash_flow": -7263000.0, "net_income": -25991000.0, "operating_cash_flow": -6445000.0, "operating_income": -25513000.0, "revenue": 20789000.0, "stockholders_equity": 25792000.0, "total_assets": 82143000.0, "total_liabilities": 56351000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 2.184824751861042, "net_margin": -1.2502284862186734, "operating_margin": -1.2272355572658618, "revenue_growth_yoy": 0.3196851393385387, "roa_avg2y": -0.41144204969091586, "roa_period_end": -0.3164116236319589, "roe_avg2y": -1.3182025663133337, "roe_period_end": -1.007715570719603 } }, { "accn": "0001564590-22-007832", "filed": "2022-03-01", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "capex": "USD", "cash": "USD", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "capex": 1478000.0, "cash": 36709000.0, "free_cash_flow": -22238000.0, "net_income": -21785000.0, "operating_cash_flow": -20760000.0, "operating_income": -21811000.0, "revenue": 15753000.0, "stockholders_equity": 13642000.0, "total_assets": 44198000.0, "total_liabilities": 30556000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 2.239847529687729, "net_margin": -1.3829111915190757, "operating_margin": -1.3845616707928647, "roa_period_end": -0.49289560613602423, "roe_avg2y": -0.9185007167552071, "roe_period_end": -1.596906611933734 } }, { "accn": "0001564590-21-009872", "filed": "2021-03-01", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "stockholders_equity": "USD" }, "fundamentals": { "stockholders_equity": 33794000.0 }, "period_end": "2017-12-31", "ratios": {} } ], "latest_filing": { "accn": "0001193125-26-088391", "filed": "2026-03-03", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0001768224.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0001768224.json" }, "ticker": "ARCT" }